HomeTagsMathematics

mathematics - Page 2

Stories from mathematics come first, newest first, then stories from connected topics (Lean, AI Science & Health, research, AI for science, AI, OpenAI), each labelled with where it comes from. This view is not indexed by search engines.

Latest

Berkeley GPCPI Reads Label-Free Optical Cell Fingerprints

UC Berkeley’s GPCPI reads label-free optical fingerprints of skin cell lines in a lab test reported in Optica. It is a proof of concept, not a diagnostic.

CUHK’s RhoAgent Virtual Scientist Designs Working RNA

CUHK’s RhoAgent designed working RNA in lab tests, Nature Biotechnology reports. The results are laboratory findings, not a therapy.

ECMWF Starts Forecast-in-a-Box Weather Pilot in Malawi

ECMWF is piloting Forecast-in-a-Box in Malawi with MET Norway and DCCMS. It is a portable AI weather system in a pilot, with no published accuracy figures.

Nature Cancer Publishes THREADS Pathology Foundation Model

Mass General Brigham’s THREADS pathology model is published in Nature Cancer after a Jan 2025 preprint. It is a research result, not a clinical product.

Fujitsu, NCCHE and Paradigm Test AI Clinical-Trial Matching

Fujitsu, NCCHE and Paradigm report AI trial-matching from a simulated, single-centre ESMO poster. The results do not guarantee trial participation.

MIT Tests a Gel-Free Material for Wearable Ultrasound Patches

MIT has made a gel-free bottlebrush elastomer for wearable ultrasound, shown only in small volunteer demonstrations. It is not clinically validated.

NeuroAxis Glucose-Powered Implant Studied in Diabetic Rats

A NeuroAxis implant powered only by glucose restored glucose tolerance in diabetic rats, a Nature paper says. It has not been tested in people.

OpenAI Says Models Improved AMD Flagship Chip Design 14%

OpenAI says its models delivered up to 14% PPA gains on AMD flagship chip design. AMD has welcomed the work on X. The year-of-progress line is OpenAI's.

Isomorphic Labs and Merck Start an Oncology Collaboration

Isomorphic Labs and Merck (MSD) will design small-molecule candidates for an unnamed oncology target. No deal value, timelines or results were disclosed.

XJTU and EPFL Report 27.96% Certified Perovskite Cells

XJTU and EPFL report perovskite cells at 27.96% certified PCE and 27.84% SPO. The 2,000-hour test used unencapsulated cells under nitrogen at about 45 °C.

Latest on TSN

Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.